Qualitests diabetes insulin syringe recalled

Qualitest Pharmaceuticals and the FDA notified patients and healthcare professionals of a voluntary nationwide recall of two lots of Accusure diabetes insulin syringes because they have been found to have needles which can detach from the syringe.

When the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into the syringe, or remain in the skin after an injection. Physicians are advised to tell consumers who have any recalled Accusure insulin syringes (31 G –Short Needle-either 1/2 cc or 1 cc, lot number 6JCB1 or lot number 7CPT1) to stop using them and contact Qualitest at 1-800-444-4011 for product replacement instructions, according to the agency and Huntsville, Ala.-based company.

The recalled products were distributed from January 2007 through June 2008 to wholesalers and retail pharmacies across the U.S., including Puerto Rico.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.